Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.67097
- By:
- Publication type:
- Article
Works matching AU Wittmann, Bryan M.
Results: 6
1
2
Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0115870
- By:
- Publication type:
- Article
3
Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming.
- Published in:
- Pulmonary Circulation, 2012, v. 2, n. 2, p. 201, doi. 10.4103/2045-8932.97606
- By:
- Publication type:
- Article
4
Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing.
- Published in:
- Journal of Mass Spectrometry, 2018, v. 53, n. 11, p. 1143, doi. 10.1002/jms.4292
- By:
- Publication type:
- Article
5
The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1.
- Published in:
- Oncogene, 2005, v. 24, n. 36, p. 5576, doi. 10.1038/sj.onc.1208728
- By:
- Publication type:
- Article
6
HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens.
- Published in:
- Biochemical Journal, 2014, v. 462, n. 2, p. 315, doi. 10.1042/BJ20140174
- By:
- Publication type:
- Article